AMYLIN PHARMACEUTICALS INC Research and Development Expense
AMYLIN PHARMACEUTICALS INC reported Research and Development Expense of $42.26 million for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2012-08-03
- AMYLIN PHARMACEUTICALS INC research and development expense for the quarter ending 2012-06-30 was $42.26M, a 6.23% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC research and development expense for the quarter ending 2012-03-31 was $51.24M, a 22.24% increase year-over-year.
- AMYLIN PHARMACEUTICALS INC research and development expense for the quarter ending 2011-12-31 was $27.67M, a 26.23% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC research and development expense for the quarter ending 2011-09-30 was $46.56M, a 8.98% decline year-over-year.
- AMYLIN PHARMACEUTICALS INC research and development expense for fiscal 2011 was $161.22M, a 11.94% decline from fiscal 2010.
- AMYLIN PHARMACEUTICALS INC research and development expense for fiscal 2010 was $183.08M, a 7.74% decline from fiscal 2009.
- AMYLIN PHARMACEUTICALS INC research and development expense for fiscal 2009 was $198.44M, a 10.86% decline from fiscal 2008.
- AMYLIN PHARMACEUTICALS INC research and development expense for fiscal 2008 was $222.61M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2012-06-30 | $42.26M 10-Q · filed 2012-08-03 | $93.50M 10-Q · filed 2012-08-03 | $121.17M derived: sum of 3 quarters · filed 2012-08-03 | $167.73M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2012-03-31 | $51.24M 10-Q · filed 2012-05-07 | $78.91M derived: sum of 2 quarters · filed 2012-05-07 | $125.47M derived: sum of 3 quarters · filed 2012-05-07 | $170.54M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2011-12-31 | $27.67M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $74.23M derived: sum of 2 quarters · filed 2012-02-22 | $119.30M derived: sum of 3 quarters · filed 2012-08-03 | $161.22M 10-K · filed 2012-02-22 | ||||
| 2011-09-30 | $46.56M 10-Q · filed 2011-10-28 | $91.63M derived: sum of 2 quarters · filed 2012-08-03 | $133.54M 10-Q · filed 2011-10-28 | $171.05M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2011-06-30 | $45.07M 10-Q · filed 2012-08-03 | $86.98M 10-Q · filed 2012-08-03 | $124.49M derived: sum of 3 quarters · filed 2012-08-03 | $175.65M derived: sum of 4 quarters · filed 2012-08-03 | ||||
| 2011-03-31 | $41.91M 10-Q · filed 2012-05-07 | $79.42M derived: sum of 2 quarters · filed 2012-05-07 | $130.58M derived: sum of 3 quarters · filed 2012-05-07 | $179.74M derived: sum of 4 quarters · filed 2012-05-07 | ||||
| 2010-12-31 | $37.51M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $88.66M derived: sum of 2 quarters · filed 2012-02-22 | $137.82M derived: sum of 3 quarters · filed 2012-02-22 | $183.08M 10-K · filed 2012-02-22 | $171.31M 10-K · filed 2011-02-25 | |||
| 2010-09-30 | $51.16M 10-Q · filed 2011-10-28 | $48.44M 10-Q · filed 2010-11-08 | $100.31M derived: sum of 2 quarters · filed 2011-10-28 | $145.57M 10-Q · filed 2011-10-28 | $136.26M 10-Q · filed 2010-11-08 | $209.12M derived: sum of 4 quarters · filed 2012-02-22 | ||
| 2010-06-30 | $49.16M 10-Q · filed 2011-08-08 | $45.99M 10-Q · filed 2010-08-05 | $94.42M 10-Q · filed 2011-08-08 | $87.82M 10-Q · filed 2010-08-05 | $157.97M derived: sum of 3 quarters · filed 2012-02-22 | $193.31M derived: sum of 4 quarters · filed 2012-02-22 | ||
| 2010-03-31 | $45.26M 10-Q · filed 2011-05-05 | $108.81M derived: sum of 2 quarters · filed 2012-02-22 | $144.16M derived: sum of 3 quarters · filed 2012-02-22 | $196.95M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | $63.55M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $98.89M derived: sum of 2 quarters · filed 2012-02-22 | $151.69M derived: sum of 3 quarters · filed 2012-02-22 | $198.44M 10-K · filed 2012-02-22 | $185.06M 10-K · filed 2011-02-25 | |||
| 2009-09-30 | $35.35M 10-Q · filed 2010-11-08 | $88.14M derived: sum of 2 quarters · filed 2010-11-08 | $134.89M 10-Q · filed 2010-11-08 | |||||
| 2009-06-30 | $52.80M 10-Q · filed 2010-08-05 | $99.55M 10-Q · filed 2010-08-05 | ||||||
| 2008-12-31 | $222.61M 10-K · filed 2011-02-25 |